LDI is a company providing pharmacy benefits services to various entities in the United States, including health insurance agents, brokers, and consultants, as well as third-party administrators and self-insured organizations. Established in 1967 and headquartered in Creve Coeur, Missouri, with satellite offices in Kansas City, Missouri, Phoenix, Arizona, and Tulsa, Oklahoma, the company offers a wide range of services.
LDI's offerings encompass disease management, therapeutic substitution, mail order convenience and support products, an integrated specialty bio-injectable program, medical pharmacy claims re-pricing, oncology center support, and home infusion therapy. The company specializes in specialty pharmacy cost management, mail-order pharmacy, generic drug education, step therapy, and formulary design. Moreover, LDI administers prescription drug programs for unions, HMOs, brokers, and self-funded employers.
In October 2016, LDI received a Private Equity Round investment from Oak HC/FT and Nautic. The company's operations revolve around promoting the health and well-being of prescription plan members through its online RxPortal and Health Envelope programs, providing plan information, patient education, and wellness programs.
With key involvements in the Health Care, Insurance, and Pharmaceutical industries, LDI continues to play a significant role in the healthcare ecosystem, offering comprehensive pharmacy benefits services to diverse organizations and individuals.
No recent news or press coverage available for LDI.